Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
NCT07652242
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- START Midwest Grand Rapids, Michigan, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
NCT07705334
- Conditions
- Adenoma, Advanced or Metastatic Solid Tumors, Breast Diseases, +40 more
- Locations
-
- SCRI at HCA HealthONE Denver, Colorado, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- NEXT Oncology San Antonio, Texas, United States
NCT07020117
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
- Locations
-
- City of Hope Duarte, California, United States
- Hoag Memorial Hospital Presbyterian Irvine, California, United States
- Biogenix Molecular, LLC Miami, Florida, United States
- Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
NCT07029399
- Conditions
- Breast Diseases, Breast Neoplasms, CCNE1 Amplified Advanced Solid Tumors, +12 more
- Locations
-
- City of Hope Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
Study of XB010 in Subjects With Solid Tumors
NCT06545331
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +31 more
- Locations
-
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
- UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
- Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
NCT07513311
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT04981119
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- Mayo Clinic Hospital Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- University of California San Diego La Jolla, California, United States
NCT07276880
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- University of North Carolina Chapel Hill, North Carolina, United States
NCT05985655
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +34 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- START Midwest Grand Rapids, Michigan, United States
- START San Antonio San Antonio, Texas, United States
- START Mountain Region West Valley City, Utah, United States
NCT07069595
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
- Locations
-
- UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
NCT07190469
- Conditions
- Advanced Solid Tumors Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
- NEXT Oncology San Antonio, Texas, United States
- START Mountain Region West Valley City, Utah, United States
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
NCT07182149
- Conditions
- Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
- Locations
-
- Normunity Investigational Site Denver, Colorado, United States
- Normunity Investigational Site New Haven, Connecticut, United States
- Normunity Investigational Site Minneapolis, Minnesota, United States
- Normunity Investigational Site Maumee, Ohio, United States
NCT05107674
- Conditions
- Adenoma, Adnexal Diseases, Breast Diseases, +75 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Colorado School of Medicine Aurora, Colorado, United States
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
NCT07218003
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- START Midwest Grand Rapids, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
NCT06885424
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- NYU Langone Medical Center New York, United States
NCT02178722
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- US Davis Cancer Center Sacramento, California, United States
- University Of Colorado Cancer Center Aurora, Colorado, United States
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
NCT05891171
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Jacksonville, Florida, United States
- Research Site Lake City, Florida, United States
- Research Site Hinsdale, Illinois, United States
Onvansertib + Paclitaxel In TNBC
NCT05383196
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
NCT05949021
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- RWJBarnabas Health - Trinitas hospital and Comprehensive Center Elizabeth, New Jersey, United States
- RWJBarnabas Health Jersey City Medical Center Jersey City, New Jersey, United States
- RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
A Study of ADRX-0706 in Select Advanced Solid Tumors
NCT06036121
- Conditions
- Breast Diseases, Breast Neoplasms, Cervical Cancer, +19 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCLA Los Angeles, California, United States
- Comprehensive Hematology Oncology St. Petersburg, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States